Prestige Consumer Healthcare Inc. (PBH): Price and Financial Metrics
Prestige Consumer Healthcare Inc. (PBH)
Today's Latest Price: $36.67 USD
Updated Nov 27 5:00pm
Add PBH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 70 in Medical - Services
See all "A" rated Strong Buy stocks
PBH Stock Summary
- For PBH, its debt to operating expenses ratio is greater than that reported by 85.45% of US equities we're observing.
- In terms of twelve month growth in earnings before interest and taxes, Prestige Consumer Healthcare Inc is reporting a growth rate of 372.71%; that's higher than 96.06% of US stocks.
- In terms of volatility of its share price, PBH is more volatile than merely 4.52% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Prestige Consumer Healthcare Inc, a group of peers worth examining would be COOP, ARCO, IDCC, VIRT, and OSN.
- Visit PBH's SEC page to see the company's official filings. To visit the company's web site, go to www.prestigebrands.com.
PBH Stock Price Chart Interactive Chart >
PBH Price/Volume Stats
| Current price | $36.67 | 52-week high | $46.12 |
| Prev. close | $36.37 | 52-week low | $27.40 |
| Day low | $35.88 | Volume | 126,392 |
| Day high | $36.80 | Avg. volume | 450,340 |
| 50-day MA | $35.30 | Dividend yield | N/A |
| 200-day MA | $37.56 | Market Cap | 1.84B |
Prestige Consumer Healthcare Inc. (PBH) Company Bio
Prestige Brands Holdings markets and distributes brand name over-the-counter health-care and household products throughout the U.S., Canada, Australia, and in certain other international markets. Core brands include Monistat women's health products, Nix lice treatments, Chloraseptic sore throat treatments, Compound W wart treatments, Clear Eyes eye care products, Little Remedies pediatric products, The Doctor's NightGuard dental protector, Efferdent denture care products, Luden's throat drops, Dramamine motion sickness treatments, BC and Goody's headache remedies, Beano gas prevention, Debrox earwax remover, and in Canada, Gaviscon antacid. The company was founded in 1996 and is based in Tarrytown, New York.
PBH Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $36.67 | $61.97 | 72% |
Below please find a table outlining a discounted cash flow forecast for PBH, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Prestige Consumer Healthcare Inc ranked in the 59th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. In terms of the factors that were most noteworthy in this DCF analysis for PBH, they are:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 54. Notably, its equity weight is greater than just 13.34% of US equities in the Healthcare sector yielding a positive free cash flow.
- The business' balance sheet suggests that 46% of the company's capital is sourced from debt; this is greater than 72.72% of the free cash flow producing stocks we're observing.
- Prestige Consumer Healthcare Inc's weighted average cost of capital (WACC) is 7%; for context, that number is higher than merely 8.66% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 68% |
| 1% | 70% |
| 2% | 72% |
| 3% | 73% |
| 4% | 75% |
| 5% | 77% |
Want more companies with a valuation profile/forecast similar to that of Prestige Consumer Healthcare Inc? See DGX, JAZZ, CAH, HCSG, and ANIP.
Loading social stream, please wait...